These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 20145213)
1. BRAF inhibitors: research accelerates in wake of positive findings. Brower V J Natl Cancer Inst; 2010 Feb; 102(4):214-5. PubMed ID: 20145213 [No Abstract] [Full Text] [Related]
2. Is it good or bad to find a BRAF mutation? Flaherty KT J Clin Oncol; 2011 Apr; 29(10):1229-30. PubMed ID: 21343552 [No Abstract] [Full Text] [Related]
3. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. Long GV; Menzies AM; Nagrial AM; Haydu LE; Hamilton AL; Mann GJ; Hughes TM; Thompson JF; Scolyer RA; Kefford RF J Clin Oncol; 2011 Apr; 29(10):1239-46. PubMed ID: 21343559 [TBL] [Abstract][Full Text] [Related]
5. [Selective blockade of the mutated BRAF leads to a survival benefit in patients with metastatic melanoma]. Schadendorf D J Dtsch Dermatol Ges; 2011 Apr; 9(4):340. PubMed ID: 21439018 [No Abstract] [Full Text] [Related]
6. A new standard of care for metastatic melanoma? Sharma SP Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638559 [No Abstract] [Full Text] [Related]
8. [BRAF mutation testing for the choice of melanoma treatment]. Imianitov EN Arkh Patol; 2012; 74(5):65-71. PubMed ID: 23342664 [TBL] [Abstract][Full Text] [Related]
9. BRAF, a target in melanoma: implications for solid tumor drug development. Flaherty KT; McArthur G Cancer; 2010 Nov; 116(21):4902-13. PubMed ID: 20629085 [TBL] [Abstract][Full Text] [Related]
10. Cancer research. Melanoma drug vindicates targeted approach. Garber K Science; 2009 Dec; 326(5960):1619. PubMed ID: 20019269 [No Abstract] [Full Text] [Related]
11. Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma. Koers K; Francken AB; Haanen JB; Woerdeman LA; van der Hage JA J Clin Oncol; 2013 Jun; 31(16):e251-3. PubMed ID: 23569313 [No Abstract] [Full Text] [Related]
12. Selumetinib increases the efficacy of first-line dacarbazine. Cancer Discov; 2013 Jul; 3(7):OF16. PubMed ID: 23847359 [TBL] [Abstract][Full Text] [Related]
13. The new arms race against melanoma. Lejeune FJ Melanoma Res; 2006 Feb; 16(1):1-2. PubMed ID: 16432449 [No Abstract] [Full Text] [Related]
14. Novel inhibitors in the treatment of metastatic melanoma. Kalinsky K; Haluska FG Expert Rev Anticancer Ther; 2007 May; 7(5):715-24. PubMed ID: 17492934 [TBL] [Abstract][Full Text] [Related]
15. BRAF mutation analysis of only one metastatic lesion can restrict the treatment of melanoma: a case report. Richtig E; Schrama D; Ugurel S; Fried I; Niederkorn A; Massone C; Becker JC Br J Dermatol; 2013 Feb; 168(2):428-30. PubMed ID: 22775439 [No Abstract] [Full Text] [Related]
16. [Melanoma and search for therapeutic targets]. de la Fouchardière A Ann Pathol; 2011 Nov; 31(5 Suppl):S123-4. PubMed ID: 22054449 [No Abstract] [Full Text] [Related]
17. BRAF in melanoma: current strategies and future directions. Salama AK; Flaherty KT Clin Cancer Res; 2013 Aug; 19(16):4326-34. PubMed ID: 23770823 [TBL] [Abstract][Full Text] [Related]
18. Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors. Falanga A; Marchetti M; Massi D; Merelli B; Verzeroli C; Russo L; Rulli E; Tondini C; Legramandi L; Nassini R; Scatena C; De Logu F; Cattaneo L; Mandalà M J Am Acad Dermatol; 2016 Jun; 74(6):1254-1256.e4. PubMed ID: 27185428 [No Abstract] [Full Text] [Related]
19. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs. Yeh AH; Bohula EA; Macaulay VM Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137 [TBL] [Abstract][Full Text] [Related]
20. Two cases of immune thrombocytopenia associated with pembrolizumab. Le Roy A; Kempf E; Ackermann F; Routier E; Robert C; Turpin A; Marabelle A; Mateus C; Michot JM; Lambotte O Eur J Cancer; 2016 Feb; 54():172-174. PubMed ID: 26687374 [No Abstract] [Full Text] [Related] [Next] [New Search]